Literature DB >> 16229213

Persistent strabismus after cataract extraction.

Mirjana P Dujić1, Katarina R Misailović, Milena M Kovacević.   

Abstract

BACKGROUND: Transient ocular misalignment as a complication of parabulbar and peribulbar anesthesia has already been reported in the literature. The aim of our study was to present a case of irreversible iatrogenic vertical strabismus after cataract surgery, which had to be operated on.
METHODS: Clinical and orthoptic evaluation of a female patient with vertical diplopia after phacoemulsification cataract surgery.
RESULTS: One week after the uneventful surgery, a 68-year-old patient complained of a sudden vertical deviation in the operated eye. The patient had not had a history of previous motility disorders. On examination, the patient showed hypertropia in the left eye of 15-20 degrees in primary position. Three and 6 months postoperatively, there was no a spontaneous improvement, while the persistent vertical deviation was 40 prism dioptres. Strabismus surgery was required 1 year after the cataract surgery.
CONCLUSION: Diplopia is a complication of peribulbar anesthesia which could be persistent. The superior and inferior rectus muscle are especially vulnerable. Its occurrence may be technique--related and the incidence increases when hyaluronidase is not available.

Entities:  

Mesh:

Year:  2005        PMID: 16229213     DOI: 10.2298/vsp0509689d

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  2 in total

1.  Cataract surgery is not associated with post-operative binocular vision anomalies in age-related cataract patients.

Authors:  Qing-Qing Tan; James S Lewis; Chang-Jun Lan; Xuan Liao; Xiao-Li Tang; Jingyun Wang; Saeed Aljohani; Mitchell M Scheiman
Journal:  Ophthalmic Physiol Opt       Date:  2022-06-12       Impact factor: 3.992

2.  Preoperative binocular vision characteristics in the age-related cataract population.

Authors:  Qing-Qing Tan; James S Lewis; Chang-Jun Lan; Xuan Liao; Xiao-Li Tang; Jingyun Wang; Mitchell M Scheiman
Journal:  BMC Ophthalmol       Date:  2022-04-27       Impact factor: 2.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.